全球心肺运动测试市场规模、份额、趋势和成长分析报告（2026-2034年）

预计到 2034 年，心肺运动测试市场规模将从 2025 年的 47.6 亿美元成长至 93 亿美元，2026 年至 2034 年的复合年增长率为 7.72%。

随着医疗机构日益重视心臟和肺部疾病的早期诊断和功能评估，全球心肺运动试验市场正稳步扩张。心肺运动试验系统在医院、运动医学中心和研究机构的应用日益广泛，用于评估运动能力和疾病进展。慢性呼吸系统和心臟疾病盛行率的上升是推动市场需求的主要因素。

成长要素包括代谢车、携带式检测设备和整合诊断软体的技术进步。人们对预防医学和健身监测意识提升也促进了市场扩张。此外，新兴国家人口老化和医疗费用支出不断增长，也为这些技术的普及应用创造了有利环境。

展望未来，数位健康平台和远端监测功能的整合有望简化临床工作流程。术前风险评估和復健计划等应用领域的拓展预计将推动市场成长。随着技术的不断创新和对精准诊断需求的日益增长，心肺运动测试市场预计将保持持续稳定的成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球心肺运动测试市场：依产品划分

• 市场分析、洞察与预测
• 单光子发射电脑断层扫描（SPECT）
• 心肺运动试验（CPET）系统
• 心臟超音波图
• 脉搏血氧饱和度分析仪
• 用于压力测试的血压计
• 其他的

第五章：全球心肺运动测试市场：依应用领域划分

• 市场分析、洞察与预测
• 氧气摄入量
• 二氧化碳
• 分钟通气量
• 无氧工作阈值

第六章：全球心肺运动测试市场：依最终用户划分

• 市场分析、洞察与预测
• 诊断中心
• 门诊中心
• 诊所
• 医院
• 其他的

第七章 全球心肺运动测试市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Masimo
  • Hill-Rom Holdings Inc
  • Schiller Healthcare India Pvt. Ltd
  • Vyaire Medical Inc
  • MGC Diagnostics Corporation
  • Cardinal Health
  • Nihon Kohden Corporation
  • COSMED Srl
  • Koninklijke Philips NV
  • GE Healthcare
  • Halma Plc

The Cardiopulmonary Exercise Testing Market size is expected to reach USD 9.30 Billion in 2034 from USD 4.76 Billion (2025) growing at a CAGR of 7.72% during 2026-2034.

The Global Cardiopulmonary Exercise Testing Market is expanding steadily as healthcare providers emphasize early diagnosis and performance assessment of cardiovascular and pulmonary conditions. CPET systems are increasingly used in hospitals, sports medicine centers, and research institutions to evaluate exercise capacity and disease progression. Rising prevalence of chronic respiratory and cardiac disorders is driving market demand.

Growth drivers include technological advancements in metabolic carts, portable testing devices, and integrated diagnostic software. Increasing awareness about preventive healthcare and fitness monitoring is also supporting market expansion. Furthermore, the growing aging population and rising healthcare expenditure in emerging economies are creating favorable conditions for adoption.

Looking ahead, integration of digital health platforms and remote monitoring capabilities will enhance clinical workflow efficiency. Expanding applications in pre-surgical risk assessment and rehabilitation programs are expected to broaden market scope. With continuous innovation and rising demand for precision diagnostics, the cardiopulmonary exercise testing market is positioned for sustainable and consistent growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Single-Photon Emission Computed Tomography (SPECT)
• Cardiopulmonary Exercise Testing (CPET) Systems
• Echocardiogram
• Pulse Oximeters
• Stress Blood Pressure Monitors
• Others

By Application

• Oxygen Uptake
• Carbon Dioxide
• Minute Ventilation
• Anaerobic Threshold

By End User

• Diagnostic Centers
• Ambulatory Centers
• Clinics
• Hospitals
• Others

COMPANIES PROFILED

• Masimo, HillRom Holdings Inc, Schiller Healthcare India Pvt Ltd, Vyaire Medical Inc, MGC Diagnostics Corporation, Cardinal Health, Nihon Kohden Corporation, COSMED srl, Koninklijke Philips NV, GE Healthcare, Halma plc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Single-Photon Emission Computed Tomography (SPECT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cardiopulmonary Exercise Testing (CPET) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Echocardiogram Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Pulse Oximeters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Stress Blood Pressure Monitors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oxygen Uptake Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Carbon Dioxide Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Minute Ventilation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Anaerobic Threshold Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CARDIOPULMONARY EXERCISE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Masimo
  • 9.2.2 Hill-Rom Holdings Inc
  • 9.2.3 Schiller Healthcare India Pvt. Ltd
  • 9.2.4 Vyaire Medical Inc
  • 9.2.5 MGC Diagnostics Corporation
  • 9.2.6 Cardinal Health
  • 9.2.7 Nihon Kohden Corporation
  • 9.2.8 COSMED Srl
  • 9.2.9 Koninklijke Philips N.V
  • 9.2.10 GE Healthcare
  • 9.2.11 Halma Plc